Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • MolMed S.p.A completes rights offering

    MolMed S.p.A. (Milan:MLM), Milan, Italy Business: Cancer Date completed: 2015-04-09 Type: Rights offering Raised: EUR49.8 million ($52.6 million) Shares: 187.3 million Price: EUR0.27 Shares after offering: 421.5 million

    Published on 4/20/2015
  • Novacyt S.A completes private placement

    Novacyt S.A. (Euronext:ALNOV), Velizy-Villacoublay, France Business: Supply/Service Date completed: 2015-04-13 Type: Private placement Raised: EUR2.2 million ($2.3 million) Shares: 442,000 Shares after offering: 6.7 …

    Published on 4/20/2015
  • Omeicos Therapeutics completes venture financing

    Omeicos Therapeutics GmbH, Berlin, Germany Business: Cardiovascular Date completed: 2015-04-15 Type: Venture financing Raised: EUR6.2 million ($6.5 million) Investors: Vesalius Biocapital Partners; SMS Investments; VC …

    Published on 4/20/2015
  • Peptonic Medical A completes private placement

    Peptonic Medical AB (AktieTorget:PMED), Vaxjo, Sweden Business: Endocrine/Metabolic, Genitourinary Date completed: 2015-03-31 Type: Private placement Raised: SEK14.5 million ($1.7 million) Shares: 1.5 million Price: …

    Published on 4/20/2015
  • Pernix Therapeutics Holdings Inc completes private placement of senior convertible notes

    Pernix Therapeutics Holdings Inc. (NASDAQ:PTX), Morristown, N.J. Business: Infectious Date completed: 2015-04-17 Type: Private placement of senior convertible notes Raised: $130 million Shares outstanding prior: 38.4 …

    Published on 4/20/2015
  • ProMetic Life Sciences Inc completes follow-on

    ProMetic Life Sciences Inc. (TSX:PLI; OTCQX:PFSCF), Laval, Quebec Business: Cancer, Autoimmune, Dermatology Date completed: 2015-04-14 Type: Follow-on Raised: C$50.1 million ($39.6 million) Shares: 19.3 million Price: C…

    Published on 4/20/2015
  • Sage Therapeutics Inc completes follow-on

    Sage Therapeutics Inc. (NASDAQ:SAGE), Cambridge, Mass. Business: Neurology Date completed: 2015-04-15 Type: Follow-on Raised: $120 million Shares: 2.3 million Price: $52.50 Shares after offering: 28.1 million …

    Published on 4/20/2015
  • StemBioSys completes venture financing

    StemBioSys Inc., San Antonio, Texas Business: Gene/Cell therapy Date completed: 2015-04-01 Type: Venture financing Raised: $8 million Investors: Targeted Technology Fund; angel investors

    Published on 4/20/2015
  • Voyager Therapeutics completes venture financing

    Voyager Therapeutics Inc., Cambridge, Mass. Business: Neurology, Gene/Cell therapy Date completed: 2015-04-13 Type: Venture financing Raised: $60 million Investors: Brookside Capital; Partner Fund Management; Wellington…

    Published on 4/20/2015
  • XBiotech Inc completes IPO

    XBiotech Inc. (NASDAQ:XBIT), Austin, Texas Business: Antibodies Date completed: 2015-04-14 Type: IPO Raised: $76 million Shares: 4 million Price: $19 Shares after offering: 31.7 million Underwriter: WR Hambrecht

    Published on 4/20/2015
  • Castle Biosciences financial update

    Castle Biosciences Inc., Friendswood, Texas Business: Diagnostic Date announced: 2015-04-14 Note: Castle Biosciences secured a $6 million credit facility from Silicon Valley Bank. The company declined to disclose …

    Published on 4/20/2015
  • Dyax Corp financial update

    Dyax Corp. (NASDAQ:DYAX), Burlington, Mass. Business: Inflammation, Ophthalmic Date announced: 2015-04-13 Note: Dyax raised $30 million through the sale of 1.1 million shares at $27 to cover the overallotment from its …

    Published on 4/20/2015
  • Galena Biopharma Inc financial update

    Galena Biopharma Inc. (NASDAQ:GALE), Portland, Ore. Business: Cancer Date announced: 2015-04-10 Note: Galena raised $5.3 million through the sale of 3.7 million shares at $1.46 to cover the overallotment from its March …

    Published on 4/20/2015
  • Joben financial update

    Joben Bio-Medical Co. Ltd., Changzhi Township, Taiwan Business: Cancer, Neurology Date announced: 2015-04-10 Note: Joben Bio-Medical began the formal process to list on the GreTai Securities Market in Taiwan by applying…

    Published on 4/20/2015
  • New Enterprise Associates financial update

    New Enterprise Associates, Baltimore, Md. Business: Finance Date announced: 2015-04-15 Note: New Enterprise Associates raised a total of $3.2 billion for two funds, including $2.8 billion for NEA 15 and $350 million for…

    Published on 4/20/2015
  • TVM Capital financial update

    TVM Capital, Munich, Germany Business: Finance Date announced: 2015-04-13 Note: TVM Capital Life Science announced a first close of $50 million for its China BioPharma Capital I fund. The fund includes an investment …

    Published on 4/20/2015
  • Cleveland BioLabs Inc proposes follow-on

    Cleveland BioLabs Inc. (NASDAQ:CBLI), Buffalo, N.Y. Business: Cancer, Other, Hematology Date announced: 2015-04-10 Type: Follow-on To be raised: Up to $10 million Units: TBD Price prior: $3.67 Underwriter: Ladenburg …

    Published on 4/20/2015
  • DelMar Pharmaceuticals Inc proposes follow-on

    DelMar Pharmaceuticals Inc. (OTCQX:DMPI), Vancouver, B.C. Business: Cancer Date announced: 2015-04-10 Type: Follow-on To be raised: Up to $10 million Shares: TBD Price prior: $0.71 Underwriters: Maxim Group; Roth …

    Published on 4/20/2015
  • Galapagos N.V proposes follow-on

    Galapagos N.V. (Euronext:GLPG; Pink:GLPYY), Mechelen, Belgium Business: Autoimmune, Musculoskeletal, Functional genomics Date announced: 2015-04-15 Type: Follow-on To be raised: Up to $150 million Shares: TBD Price …

    Published on 4/20/2015
  • Innocoll A proposes follow-on

    Innocoll AG (NASDAQ:INNL), Athlone, Ireland Business: Drug delivery, Neurology, Infectious Date announced: 2015-04-10 Type: Follow-on To be raised: Up to $19.2 million Shares: TBD Price prior: $7.30 Underwriter: Piper …

    Published on 4/20/2015
  • Pfenex Inc proposes follow-on

    Pfenex Inc. (NYSE-M:PFNX), San Diego, Calif. Business: Biosimilars, Supply/Service Date announced: 2015-04-15 Type: Follow-on To be raised: TBD Shares: 2.3 million Price prior: $18.25 Underwriters: Barclays Capital; …

    Published on 4/20/2015
  • RXi Pharmaceuticals Corp proposes private placement of common stock and warrants

    RXi Pharmaceuticals Corp. (NASDAQ:RXII), Westborough, Mass. Business: Dermatology, Gene/Cell therapy Date announced: 2015-04-13 Type: Private placement of common stock and warrants To be raised: Up to $20 million Shares…

    Published on 4/20/2015
  • Sphere Medical Holding pl proposes placing and open offer

    Sphere Medical Holding plc (LSE:SPHR), Cambridge, U.K. Business: Diagnostic, Supply/Service Date announced: 2015-04-13 Type: Placing and open offer To be raised: Up to L13.2 million ($19.3 million) Shares: 82.4 million …

    Published on 4/20/2015
  • Clarus Therapeutics withdraws IPO

    Clarus Therapeutics Inc., Northbrook, Ill. Business: Endocrine/Metabolic Date announced: 2015-04-15 Type: IPO Underwriters: Citigroup; Credit Suisse; Canaccord; Needham Note: Clarus withdrew its IPO on NASDAQ, citing …

    Published on 4/20/2015
  • Aduro Biotech amends IPO

    Aduro Biotech Inc., Berkeley, Calif. Business: Cancer Date announced: 2015-04-06 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: BofA Merrill Lynch; Leerink Partners; William …

    Published on 4/13/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993